Literature DB >> 3856052

Increase in tumor vascular area due to increased blood flow by angiotensin II in rats.

K Hori, M Suzuki, I Abe, S Saito, H Sato.   

Abstract

For further elucidation of the microhemodynamics in tumor tissue, the "vascular level," percentage of the vascular area to tissue area, was measured in DONRYU rats. Changes in the vascular level due to angiotensin II were analyzed by a point-counting method in normal and tumor tissues within a rat transparent chamber. The vascular level in normal subcutis changed from 21.8 to 18.6% when the mean arterial pressure was elevated from 102.3 to 155.9 mmHg. The coefficient of change due to angiotensin II was 0.85. The vascular level in tumor tissue was distributed inhomogeneously from 0 to 48.5% with an average of 19.7%. It increased to 33.9% (range: 8.7-57.6%) with an elevation of the mean arterial blood pressure from 103.5 to 150.8 mmHg. The coefficient of change due to angiotensin II was 2.08 in tumor tissue. Moreover, the tumor vascular level increased at a higher rate in the areas with a lower vascular level.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3856052

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  "Two-route chemotherapy" using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats.

Authors:  H Kobayashi; K Hasuda; K Aoki; T Kuroiwa; S Taniguchi; T Baba
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules.

Authors:  P A Netti; L M Hamberg; J W Babich; D Kierstead; W Graham; G J Hunter; G L Wolf; A Fischman; Y Boucher; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Cardiovascular simulation using a multiple modeling method on a digital computer--simulation of interaction between the cardiovascular system and angiotensin II.

Authors:  T Masuzawa; Y Fukui; N T Smith
Journal:  J Clin Monit       Date:  1992-01

4.  Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

Authors:  H F Dvorak; J A Nagy; J T Dvorak; A M Dvorak
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

5.  Modification of tumour blood flow using the hypertensive agent, angiotensin II.

Authors:  G M Tozer; K M Shaffi
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

6.  A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment.

Authors:  Y Nakamoto; H Sakahara; T Saga; N Sato; S Zhao; Y Arano; Y Fujioka; H Saji; J Konishi
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation.

Authors:  O Thews; D K Kelleher; P Vaupel
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

8.  Alterations in Gene Expression of Components of the Renin-Angiotensin System and Its Related Enzymes in Lung Cancer.

Authors:  Benjamin Goldstein; Malav Trivedi; Robert C Speth
Journal:  Lung Cancer Int       Date:  2017-07-16

9.  Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure.

Authors:  C J Li; Y Miyamoto; Y Kojima; H Maeda
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Isolation and properties of tumor-derived endothelial cells from rat KMT-17 fibrosarcoma.

Authors:  N Utoguchi; A Dantakean; H Makimoto; Y Wakai; Y Tsutsumi; S Nakagawa; T Mayumi
Journal:  Jpn J Cancer Res       Date:  1995-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.